Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Amylyx Pharmaceuticals, Inc. (AMLX)
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Amylyx Pharmaceuticals, Inc. (“Amylyx” or the “Company”) (NASDAQ: AMLX). The investigation concerns whether Amylyx and/or certain of …